Skip to content

Progyny PGNY Total Equity

Total Equity at other companies

CVS Health logo
CVS HealthCVS
$77.46B+0.7%
Natera, Inc. logo
Natera, Inc.NTRA
$1.77B+43.1%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$878.58M+11.3%
Organon logo
OrganonOGN
$903M+66.6%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$505.62M+300%
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
Enterprise value$1.98B-29.6%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's total equity?
Progyny (PGNY) reported total equity of $439.34M in Q1 2026.
How has Progyny's total equity changed year-over-year?
Progyny's total equity decreased by 6.0% year-over-year, from $467.16M to $439.34M.
What is the long-term trend for Progyny's total equity?
Over 5 years (2020 to 2025), Progyny's total equity has grown at a 25.3% compound annual growth rate (CAGR), from $166.95M to $516.04M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.